EMAIL DETAILS

Got it, thank you.


Neil Callahan

Rosemont Seneca Technology Partners

Carnegie Hall Tower

152 West 57th, 47th Floor

New York, NY 10019

212-933-9965 (o)

917-945-9516 (m)

866-749-8879 (f)

www.rstp.com <http://www.rstp.com/>


Confidentiality Warning: This e-mail contains information intended only for the use of the individual or entity named above. If the reader of this e-mail is not the intended recipient or the employee or agent responsible for delivering it to the intended recipient, any dissemination, publication or copying of this e-mail is strictly prohibited. The sender does not accept any responsibility for any loss, disruption or damage to your data or computer system that may occur while using data contained in, or transmitted with, this e-mail.If you have received this e-mail in error, please immediately notify us by return e-mail. Thank you


From: Katie Dodge [mailto:kdodge@rosemontseneca.com]
Sent: Tuesday, May 13, 2014 11:29 AM
To: Neil Callahan
Cc: Rob Walker; William Lee; John DeLoche; Hunter Biden
Subject: Re: FW: Dates/Times Follow up Meeting Conshohocken- Please Respond ASAP can we confirm May 19th?


Sorry, but I cannot confirm right now. Hunter will be back on Thursday and I can discuss it with him then. - Katie


On Tue, May 13, 2014 at 9:28 AM, Neil Callahan (Rosemont Seneca) <ncallahan@rosemontseneca.com> wrote:

Hi Katie,


We have a very important 2nd meeting with Morgan Stanley in the Philly suburbs. Friday May 23rd 1-3pm – can Rob and/or Hunter make it? Both would be great as John cannot make it from the West Coast. I am sure they can grab a 5pm Amtrak back to DC.


Best,


Neil


Neil Callahan

Rosemont Seneca Technology Partners

Carnegie Hall Tower

152 West 57th, 47th Floor

New York, NY 10019

212-933-9965 (o)

917-945-9516 (m)

866-749-8879 (f)

www.rstp.com <http://www.rstp.com/>


Confidentiality Warning: This e-mail contains information intended only for the use of the individual or entity named above. If the reader of this e-mail is not the intended recipient or the employee or agent responsible for delivering it to the intended recipient, any dissemination, publication or copying of this e-mail is strictly prohibited. The sender does not accept any responsibility for any loss, disruption or damage to your data or computer system that may occur while using data contained in, or transmitted with, this e-mail.If you have received this e-mail in error, please immediately notify us by return e-mail. Thank you


From: John DeLoche [mailto:jdeloche@rosemontseneca.com]
Sent: Tuesday, May 13, 2014 9:20 AM
To: Suzanne T. Cole
Cc: William Lee; John DeLoche; Neil Callahan
Subject: Re: Dates/Times Follow up Meeting Conshohocken- Please Respond ASAP can we confirm May 19th?


We are not moving Ascent because we can do MS on the 23rd.

Sent from my iPhone


On May 13, 2014, at 6:17 AM, "Suzanne T. Cole" <suzanne@troyinv.com> wrote:

Since they are small and right in downtown SF, could you please move that meeting date to accommodate MS?


From: William Lee [mailto:will@rstp.com]
Sent: Tuesday, May 13, 2014 9:14 AM
To: Suzanne T. Cole
Cc: John DeLoche; Neil Callahan
Subject: Re: Dates/Times Follow up Meeting Conshohocken- Please Respond ASAP can we confirm May 19th?


Ascent Private Capital. My preference is to tackle MS ASAP.

William Lee

Rosemont Seneca Technology Partners (RSTP)

Sent from my iPhone


On May 13, 2014, at 6:05 AM, "Suzanne T. Cole" <suzanne@troyinv.com> wrote:

Who is the LP meeting with and can we move it? I’ve been emailing everyone about that week and would like to get Morgan Stanley on track ASAP? Please let me know & Thx STC


From: William Lee [mailto:will@rstp.com]
Sent: Tuesday, May 13, 2014 9:03 AM
To: Suzanne T. Cole
Cc: John DeLoche; Neil Callahan; Devon Archer; Sebastian Momtazi
Subject: Re: Dates/Times Follow up Meeting Conshohocken- Please Respond ASAP can we confirm May 19th?


19th we have a LP meeting in the morning in SF. 23rd we are traveling back from NY. Perhaps we have to do 28th, but I prefer not to wait so long to meet with MS.


John, what do you think?


William Lee

Rosemont Seneca Technology Partners (RSTP)

Sent from my iPhone


On May 13, 2014, at 5:34 AM, "Suzanne T. Cole" <suzanne@troyinv.com> wrote:

Can we confirm May 19th at 3:00pm? Thanks Suzanne

From: Mueller, Katja [mailto:Katja.Mueller@morganstanley.com]
Sent: Tuesday, May 13, 2014 8:32 AM
To: Suzanne T. Cole
Subject: RE: Follow up Meeting Conshohocken- Rosemont Seneca Technology Partners II, L.P.


Hi Suzanne,


Looks like the following dates would work for a meeting in West Conshohocken:


May 19: after 3:00pm

May 23: 1:00 – 3:00pm

May 28: after 11:00am


Please let me know what date/time is most convenient for the RSTP team.


Thanks,

Katja


Katja Mueller
Morgan Stanley Alternative Investment Partners | AIP
100 Front Street, 4th Floor | West Conshohocken, PA 19428
Phone: +1 610 940-4623
Katja.Mueller@morganstanley.com
www.morganstanleyaip.com

Be carbon conscious. Please consider our environment before printing this email.


From: Suzanne T. Cole [mailto:suzanne@troyinv.com]
Sent: Monday, May 12, 2014 5:41 PM
To: Markle, Neha Champaneria (IM); O'Brien, Kevin F (IM)
Cc: Sperans, James (IM); Espinal, Rose (IM); Mueller, Katja (IM)
Subject: Follow up Meeting Conshohocken- Rosemont Seneca Technology Partners II, L.P.
Importance: High


Hi Neha, Kevin and Jamey,

Neha, as requested let’s look to schedule a follow up meeting the week of May 19 or May 26th while the full Rosemont Seneca Technology Partners team is on the East Coast. I will call to follow up to see what day/time looks best for your team.


Also, wanted to share the exciting news just published Thursday in Businesswire regarding Counsyl , the third investment for Rosemont Seneca Technology Partners II, L.P. You will be hearing much about this company in the coming weeks. Counsyl has completely disrupted the lab testing space, an industry that has been dominated by a few players and seen no innovation in decades. Please take a moment to read about this company and the launch of their next test for Cancer Screening. Will follow up tomorrow on dates for Conshohocken. Best Regards, Suzanne

--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Counsyl Unveils First Highly Scalable, Automated Health Information Platform and Gives People Low Cost Access to Vital Information about Their Bodies

Counsyl Launches Inherited Cancer Screen and Advances Family Prep Screen Using Latest in Sequencing Technology To Deliver Results in Two Weeks or Less; Raises $28M To Further Product Expansion, Bringing Total Financing to $93M

Counsyl Announces 250,000 Patients Screened and 14,000 Medical Professionals Served -- Changing The Way People Make Choices About Their Lives

May 08, 2014 09:00 AM Eastern Daylight Time

SOUTH SAN FRANCISCO, Calif.--( <http://www.businesswire.com/> BUSINESS WIRE)-- <http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.counsyl.com&esheet=50860364&newsitemid=20140508005895&lan=en-US&anchor=Counsyl&index=1&md5=616b98ea2f05b83fa61c75f46fe6518e> Counsyl, a technology company that gives people access to vital information about their bodies, unveils the first scalable, comprehensive platform for people to request and receive important health information in two weeks or less. Counsyl launches the Inherited Cancer Screen starting with cancer susceptibility genes BRCA1 and BRCA2 and advances its Family Prep Screen using the latest in sequencing technology for couples planning to start a family.

“We’ve had to build our software systems from the ground up to offer a simple and intuitive experience while managing complex order flows, billing, fulfillment, and on-call counseling behind the scenes.”

Counsyl also announces it has raised $28 million in Series D financing co-led by Rosemont Seneca Technology Partners and Goldman Sachs Asset Management bringing total financing to $93 million. The company will use the funds to continue to invest in product development. By reducing the cost of previously expensive laboratory procedures, Counsyl is giving people and physicians access to medical data that is truly actionable. Today this includes an Inherited Cancer Screen and Family Prep Screen, with a future roadmap for delivering comprehensive screening for a wide range of vital health information.

“We want to make it easy and affordable for people to get screened for a wide range of meaningful information that can have a real influence on their health,” said Ramji Srinivasan, co-founder and Chief Executive Officer of Counsyl. “We have made a conscious decision to screen for diseases that give more people more choices in their lives.”

New Inherited Cancer Screen

Research shows that five to 10 percent of cancers are inherited. Counsyl’s new BRCA1 and BRCA2 screen informs men and women if they have inherited a high risk for breast, ovarian, prostate, and pancreatic cancers. Counsyl provides advanced knowledge that gives people options to prepare, plan and do things to improve their health. For example, learning this vital information can help doctors identify patients who are at high risk for certain cancers. Doctors then can recommend more frequent, advanced screening than the average guidelines suggest. Counsyl’s offerings will soon include screens for other inherited cancers.

Holly T., a hairstylist and mother from Camarillo, Calif., recently took the Counsyl Inherited Cancer Screen as cancer runs in her family. Holly said, “Knowing this information allows me to be proactive. I want to be here for my kids, and I want to do everything I can to stay healthy.”

Advances to Family Prep Screen

Using sophisticated new sequencing technology, the Counsyl Family Prep Screen gives couples who are planning to have a baby information about hundreds of diseases they may unknowingly pass to future generations. A positive result means that a prospective parent is a healthy “carrier” of a genetic disease. When both parents are carriers of the same disease, they have a one in four chance of giving birth to a child that is at risk for that disease. These are health conditions where advanced knowledge can change the way a couple approaches family planning.

“You can take control of what you’ve been given and do something with it for the positive,” notes Jennifer B., a nurse and mother who learned that she and her husband were carriers of a severe disease, Smith-Lemli-Opitz Syndrome, and chose specialized fertility treatments to have a healthy baby.

Launching Counsyl Complete Platform

In addition, the company is announcing Counsyl Complete, a platform for online communication of results between physicians and patients. Physicians who offer the Counsyl Complete service have access to a complete set of online tools to allow them to easily track, monitor and follow up with patients.

Through a private online account, physicians can give results directly to patients along with educational videos that explain the significance of the findings. Patients who have additional questions can schedule complimentary telephone counseling with an experienced medical professional from Counsyl during daytime, evening and weekend hours. Compared to the standard wait time of several weeks or months, physicians can now connect patients to a genetic counselor online and expect to receive written documentation following the call.

“In my opinion, Counsyl Complete holds the promise to revolutionize the way doctors and laboratories interact. This product is an innovation that is overdue and a welcome partnership that we hope will prove to be an asset to our practice and our patients," said Mitchell Nudelman MD, Bellegrove Ob/Gyn.

Highly Automated Counsyl Lab

Counsyl integrates sophisticated technology with custom automation in its CLIA-certified, CAP-accredited and NYS CLEP-permitted medical laboratory. Designed from the ground up by a world-class team of scientists and engineers, Counsyl’s lab has created unparalleled efficiencies in the medical testing industry.

“We are able to introduce new technology that allows us to process 10 times more samples per person than traditional molecular labs,” said Dr. Eric Evans, co-founder and Chief Science Officer at Counsyl. “Building an efficient, scalable lab that uses sophisticated machinery and algorithms to produce reliable data is a never-ending process. We’re constantly adding new hardware and evaluating new technologies to ensure that millions of people have access to critical information.”

Counsyl uses custom-built robots to process blood and saliva samples working alongside Counsyl’s team of scientists and engineers to simultaneously analyze thousands of DNA samples with precision, accuracy and unparalleled efficiency.

When a sample reaches the laboratory, Counsyl’s robots use a unique barcode to identify and track the sample from start to finish. Robotic extraction and preparation of purified DNA ensures precision, which is a vital aspect of Counsyl’s ability to analyze thousands of samples each day. These robots are engineered from machines that are used for similarly precise procedures, like laser eye surgery.

“Our team of engineers can take raw medical data and turn it into a clear online report,” said Rishi Kacker, Counsyl co-founder and VP of engineering. “We’ve had to build our software systems from the ground up to offer a simple and intuitive experience while managing complex order flows, billing, fulfillment, and on-call counseling behind the scenes.”

Counsyl Medical Professionals

Members of the Counsyl clinical team are certified by the American Board of Genetic Counseling and were recruited from top academic centers, including Johns Hopkins Hospital, Weill Cornell Medical Center and UCSF Medical Center. They are passionate about translating scientific data into actionable information to help people make educated choices that are consistent with their personal beliefs.

How To Get Counsyl

Step 1: Request
Request Counsyl online at <http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.counsyl.com&esheet=50860364&newsitemid=20140508005895&lan=en-US&anchor=www.counsyl.com&index=2&md5=8c809446d814146cb5a69553d92a34c8> www.counsyl.com. Counsyl will contact your physician to obtain medical approval. If you are planning to use insurance, you can use the Counsyl <http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.counsyl.com%2Fprice&esheet=50860364&newsitemid=20140508005895&lan=en-US&anchor=price+estimator&index=3&md5=4ff812d632e6c627b484fe2c46de8960> price estimator to help calculate the cost.

Step 2: Register
Receive a registered kit in the mail, along with instructions for sample collection.

Step 3: Submit
Submit a saliva specimen in the plastic tube provided within each kit and send the sample back to Counsyl in a prepaid envelope.

Step 4: Learn
Get your results within two weeks, with an option to review your findings with a medical professional at Counsyl.

Pricing for Counsyl

Counsyl offers people an <http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.counsyl.com%2Fprice&esheet=50860364&newsitemid=20140508005895&lan=en-US&anchor=online+price+estimator&index=4&md5=306d058acdcff869f485945d9cf44b21> online price estimator that allows them to input their insurance information and receive a quote within seconds. This upfront pricing transparency allows people to know what the price will be before a test has been performed. Eligible patients typically pay between $150-300 depending on the test and their insurance coverage.

About Counsyl

Counsyl is a technology company that strives to give millions of men and women access to vital information about their bodies so they can confidently make choices about their lives. Counsyl integrates sophisticated technology with custom automation in its CLIA-certified, CAP-accredited and NYS CLEP-permitted medical laboratory. The Counsyl Family Prep Screen has already helped hundreds of thousands of people discover critical information before having children, and the Counsyl platform now includes inherited cancer screening. Counsyl has raised a total of $93 million and is privately backed by Rosemont Seneca Technology Partners, Goldman Sachs Asset Management, Founders Fund, Felicis Ventures, David Drummond, and other high profile investors.


_____


NOTICE: If you have received this communication in error, please destroy all electronic and paper copies and notify the sender immediately. Mistransmission is not intended to waive confidentiality or privilege. Morgan Stanley reserves the right, to the extent permitted under applicable law, to monitor electronic communications. This message is subject to terms available at the following link: http://www.morganstanley.com/disclaimers. If you cannot access these links, please notify us by reply message and we will send the contents to you. By messaging with Morgan Stanley you consent to the foregoing.


--
Katie Dodge

Executive Assistant/ Office Manager

Rosemont Seneca Partners

1010 Wisconsin Ave., NW, #705

Washington, DC 20007

202-333-1880